PATENT CLAIM ANALYSIS

Application Number: 15772365
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-11
Patent Classification: ["546", "016000"]

Abstract:
The present invention is directed towards new chemical entities which primarily inhibit the human T-type calcium channels and differentially modulate other key ion channels to control cell excitability, and abnormal neuronal activity particularly involved in the development and maintenance of persistent or chronic pain, and/or neurological disorders. These novel compounds are useful in the treatment and prevention of neurological and psychiatric disorders and diseases in which these ion channels are involved. The invention is also directed towards pharmaceutical formulations comprising these compounds and the uses of these compounds.

Claim (Index 15):
The compound according to a preceding claim which is

Metadata:
- Claim Count in Document: 31.0
- Percentile: 91.0
- Lexical Diversity: 1.55
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12809160', '13908705', '12498185', '15144452', '12850534']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7979836078103798
- 35 USC 102 Novelty (BERT): 0.5278566966629151
- Combined Prediction Score: 0.7709709166956333
- Mean Citation Score: 313.04355
- Max Citation Score: 315.04916000000014
- Similarity Product: 185.36315367441887

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test